HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics.

Abstract
Raltitrexed (Tomudex) is proven effective in metastatic colorectal cancer. Between 1998-2000, 25 patients were included in a randomized phase II study comparing raltitrexed (13 patients) and the Nordic FLv regimen (12 patients). 23 patients were evaluable for response. The overall response rate was 2/12 (1 CR, 1 PR) in the raltitrexed arm and 1/11 (1 CR) in the Nordic FLv arm, respectively. There was no difference in overall survival (raltitrexed--14.7 months, Nordic FLv--15.4 months). 23 patients were evaluable for Quality of Life (QoL) analysis. 23/25 and 17/21 questionnaires (EORTC QLQ C-30) were returned at baseline and first evaluation. Raltitrexed tended to be the most toxic regimen, when looking at nausea and vomiting, appetite loss, diarrhea and global QoL. However, most patients (65%) recommended the raltitrexed treatment schedule. The total treatment cost was equal in both arms (about 6,800 EURO/patient) and the hospital/hospital hotel stay costs accounted for more than half of it.
AuthorsJ Norum, L Balteskard, T H Edna, R Laino, L Wählby, G Rønning
JournalJournal of chemotherapy (Florence, Italy) (J Chemother) Vol. 14 Issue 3 Pg. 301-8 (Jun 2002) ISSN: 1120-009X [Print] England
PMID12120887 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antimetabolites, Antineoplastic
  • Quinazolines
  • Thiophenes
  • raltitrexed
  • Leucovorin
  • Fluorouracil
Topics
  • Aged
  • Antimetabolites, Antineoplastic (administration & dosage, economics, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, economics, therapeutic use)
  • Colorectal Neoplasms (drug therapy, mortality, pathology)
  • Drug Administration Schedule
  • Female
  • Fluorouracil (administration & dosage)
  • Health Care Costs
  • Humans
  • Length of Stay
  • Leucovorin (administration & dosage)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Norway
  • Quality of Life
  • Quinazolines (administration & dosage, adverse effects, economics, therapeutic use)
  • Surveys and Questionnaires
  • Survival Analysis
  • Thiophenes (administration & dosage, adverse effects, economics, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: